The role of dietary sugars in cancer risk: A comprehensive review of current evidence

IF 2.4 Q3 Medicine Cancer treatment and research communications Pub Date : 2024-01-01 Epub Date: 2025-02-03 DOI:10.1016/j.ctarc.2025.100876
Nazmul Hasan , Omid Yazdanpanah , Barbod Khaleghi , David J. Benjamin , Arash Rezazadeh Kalebasty
{"title":"The role of dietary sugars in cancer risk: A comprehensive review of current evidence","authors":"Nazmul Hasan ,&nbsp;Omid Yazdanpanah ,&nbsp;Barbod Khaleghi ,&nbsp;David J. Benjamin ,&nbsp;Arash Rezazadeh Kalebasty","doi":"10.1016/j.ctarc.2025.100876","DOIUrl":null,"url":null,"abstract":"<div><h3>Goal of the review</h3><div>The objective of this review is to conduct a thorough examination of the current evidence regarding the correlation between dietary sugar intake and cancer risk. This will encompass the biological mechanisms, the diverse effects of various sugar types, and the potential implications for cancer treatment and dietary recommendations.</div></div><div><h3>Introduction</h3><div>Nutritional and epidemiological studies now focus much on the relationship between sugar intake and cancer. The data is still conflicting even if some studies imply that excessive sugar intake can help cancer develop by means of insulin resistance and chronic inflammation.</div></div><div><h3>Discussion</h3><div>Through processes such as insulin resistance, inflammation, and angiogenesis, dietary sugars can impact carcinogenesis. Fructose increases angiogenesis by VEGF overexpression while glucose stimulates cancer cell growth by the Warburg effect. Contradicting data on the contribution of sugar to cancer emphasizes the need of consistent research techniques to simplify these dynamics. Reducing added sugar consumption in cancer prevention and management is especially crucial given that sugar affects immune function and treatment resistance, which could lead to new therapeutic targets.</div></div><div><h3>Conclusion</h3><div>High sugar intake is linked to mechanisms such as the Warburg effect, insulin resistance, and chronic inflammation, which may contribute to cancer risk under specific conditions. However, the evidence is not universally conclusive, and additional large-scale, long-term research are required to better understand these processes. To help in cancer prevention and management, public health guidelines should emphasize reducing added sugar consumption and promoting a balanced diet rich in natural foods.</div></div>","PeriodicalId":9507,"journal":{"name":"Cancer treatment and research communications","volume":"43 ","pages":"Article 100876"},"PeriodicalIF":2.4000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer treatment and research communications","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2468294225000140","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/3 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Goal of the review

The objective of this review is to conduct a thorough examination of the current evidence regarding the correlation between dietary sugar intake and cancer risk. This will encompass the biological mechanisms, the diverse effects of various sugar types, and the potential implications for cancer treatment and dietary recommendations.

Introduction

Nutritional and epidemiological studies now focus much on the relationship between sugar intake and cancer. The data is still conflicting even if some studies imply that excessive sugar intake can help cancer develop by means of insulin resistance and chronic inflammation.

Discussion

Through processes such as insulin resistance, inflammation, and angiogenesis, dietary sugars can impact carcinogenesis. Fructose increases angiogenesis by VEGF overexpression while glucose stimulates cancer cell growth by the Warburg effect. Contradicting data on the contribution of sugar to cancer emphasizes the need of consistent research techniques to simplify these dynamics. Reducing added sugar consumption in cancer prevention and management is especially crucial given that sugar affects immune function and treatment resistance, which could lead to new therapeutic targets.

Conclusion

High sugar intake is linked to mechanisms such as the Warburg effect, insulin resistance, and chronic inflammation, which may contribute to cancer risk under specific conditions. However, the evidence is not universally conclusive, and additional large-scale, long-term research are required to better understand these processes. To help in cancer prevention and management, public health guidelines should emphasize reducing added sugar consumption and promoting a balanced diet rich in natural foods.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
膳食糖在癌症风险中的作用:对当前证据的全面回顾
综述的目的本综述的目的是对目前关于膳食糖摄入量与癌症风险之间关系的证据进行彻底的检查。这将包括生物学机制,不同类型的糖的不同影响,以及对癌症治疗和饮食建议的潜在影响。营养和流行病学研究现在主要集中在糖摄入和癌症之间的关系上。尽管一些研究暗示过量的糖摄入可以通过胰岛素抵抗和慢性炎症的方式帮助癌症的发展,但这些数据仍然存在矛盾。通过胰岛素抵抗、炎症和血管生成等过程,饮食中的糖可以影响致癌。果糖通过VEGF过度表达促进血管生成,而葡萄糖通过Warburg效应刺激癌细胞生长。关于糖对癌症的影响的相互矛盾的数据强调需要一致的研究技术来简化这些动态。考虑到糖会影响免疫功能和治疗耐药性,减少添加糖的消耗在癌症预防和管理中尤为重要,这可能会导致新的治疗靶点。结论高糖摄入与Warburg效应、胰岛素抵抗和慢性炎症等机制有关,这些机制可能在特定条件下增加癌症风险。然而,证据并不是普遍的结论性的,需要更多的大规模、长期的研究来更好地理解这些过程。为了帮助预防和管理癌症,公共卫生指南应强调减少添加糖的摄入,促进富含天然食品的均衡饮食。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
4.30
自引率
0.00%
发文量
148
审稿时长
56 days
期刊介绍: Cancer Treatment and Research Communications is an international peer-reviewed publication dedicated to providing comprehensive basic, translational, and clinical oncology research. The journal is devoted to articles on detection, diagnosis, prevention, policy, and treatment of cancer and provides a global forum for the nurturing and development of future generations of oncology scientists. Cancer Treatment and Research Communications publishes comprehensive reviews and original studies describing various aspects of basic through clinical research of all tumor types. The journal also accepts clinical studies in oncology, with an emphasis on prospective early phase clinical trials. Specific areas of interest include basic, translational, and clinical research and mechanistic approaches; cancer biology; molecular carcinogenesis; genetics and genomics; stem cell and developmental biology; immunology; molecular and cellular oncology; systems biology; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; cancer policy; and integration of various approaches. Our mission is to be the premier source of relevant information through promoting excellence in research and facilitating the timely translation of that science to health care and clinical practice.
期刊最新文献
Letter to the Editor: Partial nephrectomy vs. percutaneous thermal ablation of small renal masses. Can we define the clinical variables predicting T0 after neoadjuvant systemic therapy in bladder cancer? The Mesopancreas remains at risk in primary resectable pancreatic cancer patients: time to reappraise resectability criteria? Surgical resection for primary retroperitoneal liposarcoma: Analysis of 153 patients treated and followed at a single institution. Association between biochemical and histopathological parameters in the clinical assessment of prostate tumors in a resource-limited setting in northern Cameroon.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1